BioWorld - Tuesday, April 28, 2026

BioWorld Science

Aug. 7, 2001

View Archived Issues

Dose-response study completed for Corvas's thrombosis prophylactic rNAPc2

Read More

PhotoCure applies for approval of photodynamic skin cancer therapy throughout Europe

Read More

NCI awards Phase I SBIR grant to Kosan Biosciences for anticancer compound

Read More

FDA places TP-10 pediatric trials on hold

Read More

Novel benzothiophene HSV-1 inhibitor identified by Pfizer

Read More

YM-471 shows potent affinity and selectivity for human vasopressin V1A and V2 receptors

Read More

Chronic dronedarone differs strongly from chronic amiodarone in the canine heart

Read More

Shire's once-daily treatment for ADHD receives FDA approvable letter

Read More

Cell Pathways begins phase II trials of CP-461 in several types of cancer

Read More

Vion initiates phase II clinical trials of Triapine for metastatic breast cancer

Read More

FDA approves new seven-day treatment for community-acquired pneumonia

Read More

Novel caspase inhibitors patented by Vertex

Read More

Lilly identifies compounds useful for potentiating glutamate receptor function

Read More

Benzyl tetralins reported to have potential in treating androgen- or estrogen-mediated diseases

Read More

Oxadiazolin-2-ones with elastase inhibitory activity reported by Ono Pharmaceuticals

Read More

Merck & Co. presents new cytokine inhibitors

Read More